Feedback / Questions
AT-02 - Attralus
https://www.globenewswire.com/news-release/2024/11/12/2978891/0/en/Attralus-Therapeutic-AT-02-Receives-Orphan-Drug-Designation-from-the-U-S-FDA-for-the-Treatment-of-ATTR-Amyloidosis.html
Nov 12, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next